Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Ankara, Turkey

被引:8
|
作者
Colakoglu, Sule [1 ]
Alacam, Ruhi [1 ]
Hascelik, Gulsen [1 ]
机构
[1] Hacettepe Univ, Sch Med, Dept Clin Microbiol & Microbiol, TR-06100 Ankara, Turkey
关键词
D O I
10.1080/00365540500546290
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
From 2002 to 2003, a total of 381 consecutive S. pyogenes isolates were obtained from throat swabs (n = 337) and samples of pus (n = 31), sputum (n = 10) and blood (n = 3) at Hacettepe University Hospital. The susceptibility of the isolates to erythromycin was tested by the agar dilution method. Erythromycin resistant strains were then tested for their MICs to azithromycin, clindamycin, and penicillin, their phenotype of resistance to macrolides-lincosamides-streptogramin B (MLSB) and for the presence of macrolide resistance genes. The rate of resistance to erythromycin was 6.8%. Constitutive (cMLS(B)), inducible (iMLS(B)), and M phenotypes of resistance were detected in 7.7, 30.8, and 57.7% of resistant strains, respectively. One strain had both cMLSB and iMLSB phenotypes. All M phenotypes carried the mefA gene, all iMLSB phenotype carried the ermTR gene, 1 isolate with cMLSB phenotype harboured the ermB gene, and 1 isolate with cMLSB phenotype carried both the ermB and mefA genes. One strain which showed cMLSB and iMLSB phenotypes harboured the ermB gene.
引用
收藏
页码:456 / 459
页数:4
相关论文
共 50 条
  • [1] Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Santiago, Chile
    Palavecino, EL
    Riedel, I
    Berrios, X
    Bajaksouzian, S
    Johnson, D
    Kaplan, E
    Jacobs, MR
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) : 339 - 341
  • [2] Prevalence of Macrolide Resistance in Streptococcus pyogenes Collected in Serbia
    Pavlovic, Ljiljana
    Grego, Edita
    Sipetic-Grujicic, Sandra
    [J]. JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2010, 63 (04) : 275 - 276
  • [3] Prevalence of macrolide and tetracycline resistance mechanisms in Streptococcus pyogenes isolates and in vitro susceptibility to telithromycin
    Betriu, C
    Culebras, E
    Redondo, M
    Rodríguez-Avial, I
    Gómez, M
    Boloix, A
    Picazo, JJ
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (03) : 436 - U11
  • [4] Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types
    Michos, Athanasios G.
    Bakoula, Chrysanthi G.
    Braoudaki, Maria
    Koutouzi, Foteini I.
    Roma, Eleftheria S.
    Pangalis, Anastasia
    Nikolopoulou, Georgia
    Kirikou, Elena
    Syriopoulou, Vassiliki P.
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2009, 64 (03) : 295 - 299
  • [5] Prevalence of macrolide and tetracycline resistance mechanisms in Streptococcus pyogenes isolates and in vitro susceptibility to telithromycin -: Reply
    Griffiths, PD
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (03)
  • [6] Macrolide resistance phenotypes and mechanisms of resistance in Streptococcus pyogenes in La Rioja, Spain
    Portillo, A
    Lantero, M
    Gastañares, MJ
    Ruiz-Larrea, F
    Torres, C
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1999, 13 (02) : 137 - 140
  • [7] Macrolide prescriptions and erythromycin resistance of Streptococcus pyogenes
    Gagliotti, C
    Nobilio, L
    Milandri, M
    Moro, ML
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 42 (08) : 1153 - 1156
  • [8] Mechanisms of macrolide resistance in clinical pneumococcal isolates in a university hospital, Ankara, Turkey
    Sener, B
    Köseoglu, Ö
    Gür, D
    Bryskier, A
    [J]. JOURNAL OF CHEMOTHERAPY, 2005, 17 (01) : 31 - 35
  • [9] Prevalence and characterization of macrolide resistance in clinical isolates of Streptococcus pneumoniae and Streptococcus pyogenes from North America
    Hoban, DJ
    [J]. JOURNAL OF CHEMOTHERAPY, 2002, 14 : 25 - 30
  • [10] Low macrolide resistance in Streptococcus pyogenes in Southern Argentina
    Rubinstein, G
    Amoroso, AM
    Bavdaz, B
    Blazquez, N
    Gutkind, GO
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 25 (05) : 450 - 452